Drug Shortage Report for NORITATE
Report ID | 167954 |
Drug Identification Number | 02156091 |
Brand name | NORITATE |
Common or Proper name | NORITATE |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | METRONIDAZOLE |
Strength(s) | 1% |
Dosage form(s) | CREAM |
Route of administration | TOPICAL TOPICAL |
Packaging size | 45g |
ATC code | D06BX |
ATC description | CHEMOTHERAPEUTICS FOR TOPICAL USE |
Reason for shortage | Shortage of an inactive ingredient or component. |
Anticipated start date | |
Actual start date | 2022-08-24 |
Estimated end date | 2022-09-09 |
Actual end date | 2022-08-31 |
Shortage status | Resolved |
Updated date | 2022-09-27 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2022-09-27 | French | Compare |
v4 | 2022-09-27 | English | Compare |
v3 | 2022-08-25 | French | Compare |
v2 | 2022-08-25 | French | Compare |
v1 | 2022-08-25 | English | Compare |
Showing 1 to 5 of 5